Free Newsletter
Russia taps nanotech for drug production
Rusnano, the Russia Corporation of Nanotechnologies, is working to develop nanodrugs for cancer treatment. Its goal: Production facilities by 2014 for cancer-fighters with systems of targeted delivery--liposomes, immunoliposomes, and monoclonal antibodies. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: